首页 | 本学科首页   官方微博 | 高级检索  
     


Preclinical impact of bevacizumab on brain and tumor distribution of irinotecan and temozolomide
Authors:Lauriane Goldwirt  Kevin Beccaria  Alexandre Carpentier  Ahmed Idbaih  Charlotte Schmitt  Camille Levasseur  Marianne Labussiere  Aline Milane  Robert Farinotti  Christine Fernandez
Affiliation:1. Clinical Pharmacy Department - EA 4123, College of Pharmacy, Paris Sud University, 5 rue Jean Baptiste Clement, 92296, Chatenay Malabry, France
2. Department of Neurosurgery, Pitie-Salpetriere Hospital, AP-HP, 75013, Paris, France
4. Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, UM 75, U 1127, UMR 7225, ICM, 75013, Paris, France
5. Department of Neurooncology, Pitie-Salpetriere Hospital, AP-HP, 75013, Paris, France
6. Department of Pharmaceutical Sciences, School of Pharmacy, Lebanese American University, Byblos, Lebanon
3. Pharmacy Department, Saint Antoine Hospital, AP-HP, 75012, Paris, France
Abstract:
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号